Category: Healthcare

  • Pelvic Cancer Induced Hemorrhagic Cystitis Market

    —

    by

    The pelvic cancer induced hemorrhagic cystitis market is expected to witness substantial growth, reaching USD 3.1 billion in 2025 and projected to surpass USD 12 billion by 2035, expanding at a CAGR of 19.01%.

  • Pelvic Floor Diagnostics Market

    —

    by

    The pelvic floor diagnostics market is projected to experience steady growth, reaching USD 4,753.39 million by 2035, up from USD 3,056.74 million in 2025. The market is expected to expand at a CAGR of 7.2%

  • Pelvic Floor Stimulator Market

    —

    by

    The pelvic floor stimulator market is poised for substantial growth, reaching USD 141.39 million in 2025 and projected to surpass USD 326.41 million by 2035, expanding at a CAGR of 9.8%

  • Pelvic Reconstruction Market

    —

    by

    The global pelvic reconstruction market is anticipated to grow from USD 286.6 million in 2024 to USD 377.2 million by 2034, registering a steady CAGR of 3.8%

  • Peptide Drug Conjugates Market

    —

    by

    The peptide drug conjugates market is expected to experience significant growth, reaching USD 6.33 billion by 2035, up from USD 1.86 billion in 2025. The market is projected to expand at a CAGR of 21%

  • Peptide Receptor Radionuclide Therapy Market

    —

    by

    The global peptide receptor radionuclide therapy (PRRT) market is projected to grow significantly, from USD 592.83 million in 2024 to USD 1.4 billion by 2034, at an impressive compound annual growth rate (CAGR) of 9.2%

  • Rheumatic Heart Disease Management Market

    —

    by

    The rheumatic heart disease management market is projected to witness steady growth, with an estimated market size of USD 2.32 billion by 2035, up from USD 1.32 billion in 2025. This reflects a CAGR of 5.5%

  • Ringworm Treatment Market

    —

    by

    The global ringworm treatment market is poised for substantial growth, reaching USD 14.91 billion by 2035, up from USD 9.38 billion in 2025, reflecting an estimated CAGR of 6.2%

  • RNA-Targeted Small Molecules Market

    —

    by

    The global market for RNA-targeted small molecules is projected to experience substantial growth, fueled by increasing investments in RNA-targeted therapies. The market, valued at USD 2,454.5 million in 2025, is expected to reach USD 5,311.7 million by 2035, expanding at a CAGR of 7.3%

  • Robot-Assisted Surgical Microscope Market

    —

    by

    The global robot-assisted surgical microscope market is projected to expand from USD 411.6 million in 2024 to USD 859.0 million by 2034, growing at a compound annual growth rate (CAGR) of 8.6%